Monday, May 16, 2022 Daily Archives

Standardized handling practices would help cell therapy sector, study

Cell therapy developers need uniform handling, storage, and usage methods say the authors of a new report examining how the market for centrally manufactured products is evolving.  The study – published in the Journal of Translational Medicine in April – looked at the role medical center processing labs play in cell therapy distribution and usage and concluded that such facilities will be a potential bottleneck unless handling processes become more uniform.  “Cell processing laboratories at many academic medical centers are…

Lithuanian CDMO Northway invests $40m in MA plant

Northway will open a facility in Waltham offering microbial and mammalian cell line development and upstream and downstream process advancement. The contract development manufacturing organization (CDMO) headquartered in Vilnius, Lithuania opened its doors to international ministers for a tour of its 30,000 square foot sister facility in Waltham, which is expected to be fully operational by the end of 2022. “We selected Waltham because of its close proximity to the Boston biotech cluster, one of the premier global life sciences hubs…

Korean CDMO enters US with BMS plant buy

Lotte is set to buy Bristol-Myers Squibb’s (BMS) facility in East Syracuse, which it says will serve its CDMO business in the US. The deal, which is subject to regulatory approvals and other closing conditions, sees Korean-based firm Lotte Corporation acquire BMS’ New York site’s operations and assets. This includes the equipment, property, plant, workforce, and technical capabilities. “This transaction is consistent with our longstanding goal of creating a manufacturing network to best support the ongoing needs of the business…

PCI forks out $100m to expand New England plant

The Philadelphia-based CDMO will expand its capacity in sterile lyophilization technology and aseptic liquid fill/finish to stay ahead of demand. PCI Pharma Services says the investment of $100 million at its Bedford, New Hampshire campus will include a 50,000 square-foot facility, which will enable the contract development manufacturing organization (CDMO) to expand its service offerings in biologics packaging and manufacturing. “We are excited to introduce clients to our newest facility, which is part of our broader strategy to provide integrated…